Immutep Limited (IMMP)
NasdaqGM: IMMP
· リアルタイム株価 · USD
0.41
+0.03 (7.89%)
終値時点: Aug 13, 2026, 10:20 AM
Immutep Limited (IMMP) Stock Price, Analysis & Data
7.89% (1D)
IMMPについて
Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial fo...
企業情報の全文